SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Cadigan KM, Nusse R 1997 Wnt signaling: A common theme in animal development. Genes Dev 11: 32863305.
  • 2
    Miller JR, Hocking AM, Brown JD, Moon RT 1999 Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18: 78607872.
  • 3
    Habas R, Kato Y, He X 2001 Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell 107: 843854.
  • 4
    Wang HY, Malbon CC 2003 Wnt signaling, Ca2+, and cyclic GMP: Visualizing Frizzled functions. Science 300: 15291530.
  • 5
    Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513523.
  • 6
    Gong Y, Vikkula M, Boon L, Liu J, Beighton P, Ramesar R, Peltonen L, Somer H, Hirose T, Dallapiccola B, De Paepe A, Swoboda W, Zabel B, Superti-Furga A, Steinmann B, Brunner HG, Jans A, Boles RG, Adkins W, van den Boogaard MJ, Olsen BR, Warman ML 1996 Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12–13. Am J Hum Genet 59: 146151.
  • 7
    Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 15131521.
  • 8
    Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 1119.
  • 9
    Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA II, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L 2002 Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303314.
  • 10
    Bodine PV, Zhao W, Kharode YP, Bex FJ, Lambert AJ, Goad MB, Gaur T, Stein GS, Lian JB, Komm BS 2004 The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 18: 12221237.
  • 11
    Zakany J, Duboule D 1993 Correlation of expression of Wnt-1 in developing limbs with abnormalities in growth and skeletal patterning. Nature 362: 546549.
  • 12
    Rudnicki JA, Brown AM 1997 Inhibition of chondrogenesis by Wnt gene expression in vivo and in vitro. Dev Biol 185: 104118.
  • 13
    Kawakami Y, Wada N, Nishimatsu SI, Ishikawa T, Noji S, Nohno T 1999 Involvement of Wnt-5a in chondrogenic pattern formation in the chick limb bud. Dev Growth Differ 41: 2940.
  • 14
    Yamaguchi TP, Takada S, Yoshikawa Y, Wu N, McMahon AP 1999 T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification. Genes Dev 13: 31853190.
  • 15
    Hartmann C, Tabin CJ 2000 Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127: 31413159.
  • 16
    Hartmann C, Tabin CJ 2001 Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104: 341351.
  • 17
    Church V, Nohno T, Linker C, Marcelle C, Francis-West P 2002 Wnt regulation of chondrocyte differentiation. J Cell Sci 115: 48094818.
  • 18
    Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y 2003 Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162: 899908.
  • 19
    Hajihosseini MK, Lalioti MD, Arthaud S, Burgar HR, Brown JM, Twigg SR, Wilkie AO, Heath JK 2004 Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development 131: 325335.
  • 20
    Fischer L, Boland G, Tuan RS 2002 Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem 277: 3087030878.
  • 21
    Tufan AC, Daumer KM, Tuan RS 2002 Frizzled-7 and limb mesenchymal chondrogenesis: Effect of misexpression and involvement of N-cadherin. Dev Dyn 223: 241253.
  • 22
    Xu L, Tan L, Goldring MB, Olsen BR, Li Y 2001 Expression of frizzled genes in mouse costochondral chondrocytes. Matrix Biol 20: 147151.
  • 23
    Enomoto-Iwamoto M, Kitagaki J, Koyama E, Tamamura Y, Wu C, Kanatani N, Koike T, Okada H, Komori T, Yoneda T, Church V, Francis-West PH, Kurisu K, Nohno T, Pacifici M, Iwamoto M 2002 The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis. Dev Biol 251: 142156.
  • 24
    Kitagaki J, Iwamoto M, Liu JG, Tamamura Y, Pacifci M, Enomoto-Iwamoto M 2003 Activation of beta-catenin-LEF/TCF signal pathway in chondrocytes stimulates ectopic endochondral ossification. Osteoarthritis Cartilage 11: 3643.
  • 25
    DasGupta R, Fuchs E 1999 Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 126: 45574568.
  • 26
    Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L 1994 Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91: 93029306.
  • 27
    Baron R, Vignery A, Neff L, Silverglate A, Santa Maria A 1983 Bone histomorphometry: Techniques and interpretation. In: ReckerR (ed.) Processing of Undecalcified Bone Specimens for Bone Histomorphometry. CRC Press, Boca Raton, FL, USA, pp. 1335.
  • 28
    Kawaguchi J, Wilson V, Mee PJ 2002 Visualization of whole-mount skeletal expression patterns of LacZ reporters using a tissue clearing protocol. Biotechniques 32: 6673.
  • 29
    Horowitz MC, Fields A, DeMeo D, Qian HY, Bothwell AL, Trepman E 1994 Expression and regulation of Ly-6 differentiation antigens by murine osteoblasts. Endocrinology 135: 10321043.
  • 30
    Okubo T, Hogan BL 2004 Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. J Biol 3: 11.
  • 31
    Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S 1998 Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA 95: 43744379.
  • 32
    Jonsson M, Andersson T 2001 Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. J Cell Sci 114: 20432053.
  • 33
    Oloumi A, McPhee T, Dedhar S 2004 Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim Biophys Acta 1691: 115.
  • 34
    Wang Y, Macke JP, Abella BS, Andreasson K, Worley P, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J 1996 A large family of putative transmembrane receptors homologous to the product of the Drosophila tissue polarity gene frizzled. J Biol Chem 271: 44684476.
  • 35
    Hsieh JC, Rattner A, Smallwood PM, Nathans J 1999 Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc Natl Acad Sci USA 96: 35463551.
  • 36
    Goltzman D 2002 Discoveries, drugs and skeletal disorders. Nat Rev Drug Discov 1: 784796.
  • 37
    Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr 2003 The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349: 24832494.
  • 38
    Sen M, Lauterbach K, El-Gabalawy H, Firestein GS, Corr M, Carson DA 2000 Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA 97: 27912796.
  • 39
    Sen M, Chamorro M, Reifert J, Corr M, Carson DA 2001 Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 44: 772781.
  • 40
    Bergwitz C, Wendlandt T, Kispert A, Brabant G 2001 Wnts differentially regulate colony growth and differentiation of chondrogenic rat calvaria cells. Biochim Biophys Acta 1538: 129140.
  • 41
    Yates KE 2004 Demineralized bone alters expression of Wnt network components during chondroinduction of post-natal fibroblasts. Osteoarthritis Cartilage 12: 497505.
  • 42
    Stott NS, Jiang TX, Chuong CM 1999 Successive formative stages of precartilaginous mesenchymal condensations in vitro: Modulation of cell adhesion by Wnt-7A and BMP-2. J Cell Physiol 180: 314324.
  • 43
    Hwang SG, Ryu JH, Kim IC, Jho EH, Jung HC, Kim K, Kim SJ, Chun JS 2004 Wnt-7a causes loss of differentiated phenotype and inhibits apoptosis of articular chondrocytes via different mechanisms. J Biol Chem 279: 2659726604.
  • 44
    Yang Y, Topol L, Lee H, Wu J 2003 Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130: 10031015.
  • 45
    Akhter MP, Wells DJ, Short SJ, Cullen DM, Johnson ML, Haynatzki GR, Babij P, Allen KM, Yaworsky PJ, Bex F, Recker RR 2004 Bone biomechanical properties in LRP5 mutant mice. Bone 35: 162169.
  • 46
    Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F 2003 High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960974.
  • 47
    D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG 2000 The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275: 3264932657.
  • 48
    Leung-Hagesteijn C, Mahendra A, Naruszewicz I, Hannigan GE 2001 Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. EMBO J 20: 21602170.
  • 49
    Novak A, Dedhar S 1999 Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 56: 523537.